News & Blog

Tag Archives: FDA

Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

Advice Column, April 2018: Exploring Novel Brain Tumor Treatments

National Brain Tumor Society recently announced the launch of a new patient and care-partner education, empowerment, and preparedness effort. The new initiative will provide the resources, information, tools, and guidance brain tumor patients and their care-partners need to play a more active role in their treatment planning and decision-making. As part of the broader effort to […]

March 2018 Public Policy and Advocacy Updates

For a number of years now, our Public Policy & Advocacy staff have put out monthly emails to those who’ve signed-up to be NBTS volunteer advocates, providing updates on the latest goings-on in the world of brain tumor public policy and issues related to legislation that impacts this community. As our advocacy program continues to […]

Share